Literature DB >> 25373132

Assessing disability in schizophrenia: tools and contributors.

Philip D Harvey.   

Abstract

Patients with schizophrenia experience disability in areas of everyday life, such as employment, relationships, and independence, even after they achieve symptom remission. Clinicians can assess patients' functional disability by using information from multiple sources (patient, family member, case worker), collecting objective information, and evaluating real-life skills and cognitive abilities with performance-based assessment tools, such as the MATRICS Consensus Cognitive Battery or the University of California, San Diego, Performance-Based Skills Assessment (UPSA). Factors that contribute to functional disability include cognitive impairments and negative symptoms, which appear to have different effects on domains of functioning and likely require separate treatment interventions. © Copyright 2014 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25373132     DOI: 10.4088/JCP.13049tx5c

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

Review 1.  Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia.

Authors:  Kunal Maini; Janice W Hollier; Haley Gould; Victoria Bollich; John John LaForge; Elyse M Cornett; Amber N Edinoff; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2021-06-19

2.  The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia.

Authors:  Xiaoyan He; Qingyan Ma; Yajuan Fan; Binbin Zhao; Wei Wang; Feng Zhu; Xiancang Ma; Lina Zhou
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-21       Impact factor: 2.570

3.  Modeling the Longitudinal Effects of Insight on Depression, Quality of Life and Suicidality in Schizophrenia Spectrum Disorders: Results from the FACE-SZ Cohort.

Authors:  Mickaël Ehrminger; Mathieu Urbach; Christine Passerieux; Bruno Aouizerate; Fabrice Berna; Anne-Lise Bohec; Delphine Capdevielle; Isabelle Chereau; Julie Clauss; Caroline Dubertret; Aurélie Esselin; Catherine Faget; Guillaume Fond; Roxana Mihaela Honciuc; Marine Jarroir; Jasmina Mallet; David Misdrahi; Baptiste Pignon; Romain Rey; Franck Schürhoff; Hanan Yazbek; Eric Brunet-Gouet; Paul Roux
Journal:  J Clin Med       Date:  2019-08-10       Impact factor: 4.241

Review 4.  Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review.

Authors:  Kunal Maini; Haley Gould; Jessica Hicks; Fatima Iqbal; James Patterson; Amber N Edinoff; Elyse M Cornett; Adam M Kaye; Omar Viswanath; Ivan Urits; Alan D Kaye
Journal:  Neurol Int       Date:  2021-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.